ACTN4 facilitates the migration of a wide range of cancer cells, leading to adverse outcomes, including colorectal cancer, intrahepatic cholangio-carcinoma, lung cancer, glioblastoma, pancreatic cancer, cervical cancer, melanoma, prostate cancer, gastric cancer, and ovarian cancer. The gene discussed is ACTN4; the disease is cancer.